Captario Sweden

Based on extensive experience in Drug development, encompassing Global project leadership, modeling and simulation and portfolio management Captario was founded to create a new generation of Pharma IT.

The Colab software helps cross-functional teams define and drive a drug development strategy from CD selection to launch. Using Colab, the teams manage project uncertainties and are supported by advanced visualization, modeling and simulation in making critical decisions.

Business Type
Mr Johannes Vänngård
Managing director 
Mrs Ingela Nylander
Business Development Director 

Cellectis Sweden

  Cellectis is a biotechnology company that was founded in 1999 upon technology transferred from the Institut Pasteur, one of France’s leading institutions for science and health. The Cellectis stem cells Business Unit combines two Cellectis Group companies dedicated to stem celltechnology. These are Ectycell, based at the Evry Genopole (France), and Cellartis, based in Gothenburg (Sweden), which was acquired by Cellectis in October 2011. To find out more about Cellartis, please visit www.cellartis.com   The goal of the "Cellectis stem cells" Business Unit is to speed up the development of stem cell technology and in particular to find a robust and reproducible way of controlling stem cell production and differentiation, notably through the sharing of knowledge and expertise developed by the two companies, with a view to becoming a major, long-term and stable industrial player in the global marketplace.

Cellartis, a Swedish company founded in 2001, was formed as a spin-off from the University of Gothenburg. From its inception the company has worked on pluripotent stem cells and technologies applied to the search for new drugs, toxicity testing and regenerative medicine. Cellartis has proven expertise in many different areas including:
  • controlling stem cell differentiation into liver and heart cells which offer unrivalled performance in toxicity testing applications;
  • ownership and exploitation of the world's largest stem cell bank (30 proprietary lines);
  • effective industrial rollout of their technologies;
  • alongside leading partners, involvement in regenerative medicine programs which use the immense potential of stem cells for the restoration of damaged tissues and organs.

The Cellectis stem cells Business Unit has ambitious objectives.
  • To industrialize pluripotent stem cells;
  • To develop industrial in vitro tools predictive of human physiology and genetic diversity, such as tools for the drug and cosmetic industries, as well as for research, and that can be immediately used in industrial molecular screening and selection processes;
  • To develop major partnerships, particularly in the field of regenerative medicine;
  • To take a strategic industrial role in order to set standards in an emerging market, forge a strong pioneering position in the areas of focus, and build a genuine industrial sector based around stem cells and a competitive industrial cluster.
Business Type
Petter Björquist
LinkedIn logo VP Regenerative Medicine, Senior Principal Scientist 
Ms Katarina Emanuelsson
Business Development Manager 

Clever Collaboration Group AB Sweden

Clever Collaboration Group delivers collaboration services allowing organisations to develop and manage collaborate activities and processes with patients, doctors, relatives, any other stakeholder. Example processes our solutions are used in are "Abused Child", "Cold Case (London Police)", "Risk Assessments", North East Essex - Clinical Commissioning Group video in English (http://ccgsweden.com/referenser/vardgivare/north-east-essex.html) .

You can run sessions allowing participants to be anonymous, identified on team level, or with full name. Sessions can be samtime or anytime from anyplace. Police forces typically likes our stand-alone services allowing them to collaborate anywhere without dependancy to internet.

For more information, see www.CCGEurope.com or give us a call at +46 31 - 788 58 50

Best regards

Pierre Wettergren, CEO

Business Type
Pierre Wettergren

ClinTrials Skåne AB Sweden

ClinTrials Skåne is a public limited company dedicated to helping the life science industry developing their products in close cooperation with universities and the public health care sector in the county of Skåne. We have long experience in working with clinical trials and product development in hospitals in Skåne. Our offices are located in Skåne university hospital and in Medicon Village in Lund, with direct access to both the life science industry and the public healthcare system.

Business Type
Mrs Gertrud Lundkvist
Research coordinator 
Dr Fred Kjellson
Project manager 

CR Competence Sweden

Business Type
Catharina Salomonsson
Project Scientist